Similar articles for PMID: 20980427

Year	Number of Results
2006	3
2007	1
2008	1
2010	10
2011	4
2012	5
2013	11
2014	9
2015	14
2016	13
2017	10
2018	12
2019	9
2020	11
2021	7
2022	5
2023	3
2024	0

1

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.

Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, Mitchell P, Sharp D, Wolf-Schnurrbusch UE, Gekkieva M, Weichselberger A, Wolf S. Massin P, et al. Diabetes Care. 2010 Nov;33(11):2399-405. doi: 10.2337/dc10-0493. Diabetes Care. 2010. PMID: 20980427 Free PMC article. Clinical Trial.

2

The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.

Ishibashi T, Li X, Koh A, Lai TY, Lee FL, Lee WK, Ma Z, Ohji M, Tan N, Cha SB, Shamsazar J, Yau CL; REVEAL Study Group. Ishibashi T, et al. Ophthalmology. 2015 Jul;122(7):1402-15. doi: 10.1016/j.ophtha.2015.02.006. Epub 2015 May 14. Ophthalmology. 2015. PMID: 25983216 Clinical Trial.

3

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ; RIDE and RISE Research Group. Brown DM, et al. Ophthalmology. 2013 Oct;120(10):2013-22. doi: 10.1016/j.ophtha.2013.02.034. Epub 2013 May 22. Ophthalmology. 2013. PMID: 23706949 Free article. Clinical Trial.

4

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A; RESTORE study group. Mitchell P, et al. Ophthalmology. 2011 Apr;118(4):615-25. doi: 10.1016/j.ophtha.2011.01.031. Ophthalmology. 2011. PMID: 21459215 Free article. Clinical Trial.

5

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS; RISE and RIDE Research Group. Nguyen QD, et al. Ophthalmology. 2012 Apr;119(4):789-801. doi: 10.1016/j.ophtha.2011.12.039. Epub 2012 Feb 11. Ophthalmology. 2012. PMID: 22330964 Clinical Trial.

6

Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.

Sophie R, Lu N, Campochiaro PA. Sophie R, et al. Ophthalmology. 2015 Jul;122(7):1395-401. doi: 10.1016/j.ophtha.2015.02.036. Epub 2015 Apr 11. Ophthalmology. 2015. PMID: 25870079 Free article. Clinical Trial.

7

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.

Sahni J, Patel SS, Dugel PU, Khanani AM, Jhaveri CD, Wykoff CC, Hershberger VS, Pauly-Evers M, Sadikhov S, Szczesny P, Schwab D, Nogoceke E, Osborne A, Weikert R, Fauser S. Sahni J, et al. Ophthalmology. 2019 Aug;126(8):1155-1170. doi: 10.1016/j.ophtha.2019.03.023. Epub 2019 Mar 21. Ophthalmology. 2019. PMID: 30905643 Free article. Clinical Trial.

8

Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema.

Moshfeghi AA, Shapiro H, Lemmon LA, Gune S. Moshfeghi AA, et al. Ophthalmol Retina. 2018 Feb;2(2):86-90. doi: 10.1016/j.oret.2017.05.003. Epub 2017 Jul 27. Ophthalmol Retina. 2018. PMID: 31047350 Free article. Clinical Trial.

9

Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study.

Kinge B, Stordahl PB, Forsaa V, Fossen K, Haugstad M, Helgesen OH, Seland J, Stene-Johansen I. Kinge B, et al. Am J Ophthalmol. 2010 Sep;150(3):310-4. doi: 10.1016/j.ajo.2010.03.028. Epub 2010 Jun 29. Am J Ophthalmol. 2010. PMID: 20591399 Clinical Trial.

10

Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.

Pearce I, Banerjee S, Burton BJ, Chakravarthy U, Downey L, Gale RP, Gibson J, Pagliarini S, Patel J, Sivaprasad S, Andrews C, Brittain C, Warburton J; RELIGHT Study Group. Pearce I, et al. Ophthalmology. 2015 Sep;122(9):1811-9. doi: 10.1016/j.ophtha.2015.05.038. Epub 2015 Jul 3. Ophthalmology. 2015. PMID: 26150052 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year